Arcturus Therapeutics
ARCT
114 hedge funds and large institutions have $606M invested in Arcturus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 8 closing their positions.
822% more capital invested
Capital invested by funds: $65.7M → $606M (+$540M)
763% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 8
115% more funds holding
Funds holding: 53 → 114 (+61)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 17
31.92% more ownership
Funds ownership: 31.28% → 63.2% (+32%)
19% less call options, than puts
Call options by funds: $17M | Put options by funds: $21M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$30.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$23.6M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$21.2M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DI
DFPG Investments
Sandy,
Utah
|
-$3.86M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
-$3.85M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$3.75M |
| 4 |
Millennium Management
New York
|
-$3.24M |
| 5 |
Morgan Stanley
New York
|
-$1.72M |
ARCT Hedge Fund Activity: Q2 2020 in Review
114 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q2 2020, worth a combined $606M — up 822% from $65.7M a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new ARCT positions and 8 closed out — a net gain of 61 holders — while 25 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $30.6M. The largest seller was DFPG Investments, cutting an estimated $3.86M.
- 114 institutional investors held Arcturus Therapeutics (ARCT) as of Q2 2020, up from 53 in Q1 2020.
- Funds reported $606M of Arcturus Therapeutics stock for Q2 2020, up 822% quarter-over-quarter.
- 69 funds opened new Arcturus Therapeutics positions in Q2 2020 and 8 closed out, a net change of +61 holders.
- The largest Arcturus Therapeutics buyer in Q2 2020 was BlackRock, an estimated $30.6M added.
- The largest Arcturus Therapeutics seller in Q2 2020 was DFPG Investments, an estimated $3.86M sold.
Based on aggregated 13F filings for Q2 2020.